Blog

Enterprise Management Incentives (EMI) share options guide

Questions to ask for an EMI scheme

  Enterprise Management Incentives (EMI) share options guide COMPANIES in the biotech and tech spaces have a constant need to incentivise staff and build motivated teams to prepare them down the line for a sale or investment. Part of that process should include consideration of equity incentives and the tax implications of granting these share…

Read More

Rise and fall of film partnerships

Hollywood sign USA

A tax perspective Tax is our world. We live and breathe it and always find the most tax-efficient – and legal – solutions for our clients, that’s a given. Film partnerships do not generally figure in the tech and biotech niche we inhabit, but they’ve caught our attention in the press recently, so here’s our…

Read More

BREXIT AND TAX: WHAT’S IN STORE FOR BIOTECHS?

Union-Jack-flag-with-Brexit-word

THERE IS no doubt that biotech fundraising rounds are getting bigger, companies are getting bigger and, as tax advisors, we are being faced with previously unheard of issues. Take profits – these could result in corporation tax liabilities, groups so large or profitable that they cannot claim SME R&D tax credits or future milestone income…

Read More

Should your company elect in to the Patent Box?

Light bulbs hanging from a ceiling

You’re not out of time but don’t be out of touch… Bad Hall & Oates songs aside, the Patent Box is a complicated beast and 2018 is likely to be a crucial year for determining whether you should elect in. So here is some clarity if yours is a loss-making company. The Patent Box provides…

Read More

UK: A GREAT OPTION FOR US R&D

Triangular sign saying explore on a wooden background

WHY THE UK ROCKS FOR RESEARCH During a January visit to San Francisco to coincide with the JP Morgan conference, it was encouraging to hear from one US biotech company CFO how he considered the UK an attractive place to base his company’s research activities – above and beyond any other. Among the reasons why…

Read More